Bio Rad Laboratories Inc/ US0905722072 /
| 6/7/2024 10:10:00 PM | Chg. -1.98 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 287.02USD | -0.69% | 210,323 Turnover: 29.22 mill. |
265.69Bid Size: 100 | 307.61Ask Size: 100 | 6.73 bill.USD | - | - |
Assets
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 349.5000 | 416.9000 | 429.4000 | 428.8360 | 437.6900 | ||||||
| Intangible Assets | 259.5000 | 260.9000 | 266.2000 | 254.2280 | 214.0260 | ||||||
| Long-Term Investments | - | - | - | 389.3090 | 719.8400 | ||||||
| Fixed Assets | - | - | - | 1,624.9110 | 1,933.9460 | ||||||
| Inventories | 433.5000 | 448.4000 | 501.3000 | 470.9970 | 490.2240 | ||||||
| Accounts Receivable | 398.7000 | 398.7000 | 422.7000 | 377.6400 | 391.4850 | ||||||
| Cash and Cash Equivalents | 574.2000 | 463.4000 | 331.6000 | 413.2510 | 457.5490 | ||||||
| Current Assets | 1,798.2000 | 1,929.9000 | 1,747.9000 | 1,716.3670 | 1,777.5960 | ||||||
| Total Assets | 3,096.8000 | 3,436.8000 | 3,388.8000 | 3,341.2780 | 3,711.5420 | ||||||
Liabilities
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 129.1000 | 130.9000 | 148.5000 | 128.6080 | 122.3910 | ||||||
| Long-term debt | - | - | - | 435.7100 | 435.7070 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 85.5000 | 115.1000 | 162.1000 | 154.9000 | 233.5000 | ||||||
| Liabilities | 1,352.4000 | 1,425.5000 | 1,202.1000 | 1,156.1230 | 1,221.0390 | ||||||
| Share Capital | .0030 | .0030 | .0030 | .0020 | .0020 | ||||||
| Total Equity | 1,744.4000 | 2,011.3000 | 2,186.7000 | 2,185.1550 | 2,490.5030 | ||||||
| Minority Interests | .4000 | .5000 | 0.0000 | - | - | ||||||
| Total liabilities equity | 3,096.8000 | 3,436.8000 | 3,388.8000 | 3,341.2780 | 3,711.5420 | ||||||
Income Statement
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,073.5000 | 2,069.2000 | 2,132.7000 | 2,175.0440 | 2,019.4410 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 295.2000 | 257.2000 | 169.5000 | 149.9840 | 166.7080 | ||||||
| Interest Income | -53.1000 | -51.1000 | -61.3000 | 22.1310 | 21.6920 | ||||||
| Income Before Taxes | 235.8000 | 222.9000 | 112.4000 | 131.5570 | 145.8470 | ||||||
| Income Taxes | 57.7000 | 59.1000 | 34.6000 | -42.7120 | -32.7540 | ||||||
| Minority Interests Profit | .2000 | -.1000 | -.0200 | - | - | ||||||
| Net Income | 178.2000 | 163.8000 | 77.8000 | 88.8450 | 113.0930 | ||||||
Per Share
Cash Flow
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 259.8000 | 278.9000 | 175.5000 | 273.3120 | 186.2100 | ||||||
| Cash Flow from Investing Activities | -383.4000 | -412.8000 | -5.4000 | -190.5110 | -166.8690 | ||||||
| Cash Flow from Financing | -213.6000 | 12.6000 | -311.7000 | 11.6890 | 8.5810 | ||||||
| Decrease / Increase in Cash | -332.3000 | -110.8000 | -131.8000 | 81.7000 | 44.2980 | ||||||
| Employees | 7,030 | 7,380 | 7,750 | 7,600 | 7,700 | ||||||
